| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.03. | Tenon Medical, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 19.03. | Tenon Medical outlines growth acceleration plans following 92% Q4 revenue jump and expanded SI-Joint Fusion portfolio | 1 | Seeking Alpha | ||
| TENON MEDICAL Aktie jetzt für 0€ handeln | |||||
| 19.03. | Tenon Medical GAAP EPS of -$0.29 beats by $0.07, revenue of $1.5M beats by $0.12M | 2 | Seeking Alpha | ||
| 19.03. | Tenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2025 Financial Results | 562 | ACCESS Newswire | ~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second... ► Artikel lesen | |
| 19.03. | Tenon Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | Tenon Medical raises $4.3M through convertible note offering | 3 | Investing.com | ||
| 12.03. | Tenon Medical raises $4.3M via convertible note offering | 2 | Investing.com | ||
| 12.03. | Tenon Medical nimmt 4,3 Mio. US-Dollar durch Privatplatzierung von Wandelanleihen ein | 6 | Investing.com Deutsch | ||
| 12.03. | Tenon Medical, Inc.: Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million | 397 | ACCESS Newswire | LOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders... ► Artikel lesen | |
| 18.02. | Tenon Medical stärkt Patentportfolio mit neuen US-Zulassungen | 2 | Investing.com Deutsch | ||
| 18.02. | Tenon Medical expands patent portfolio with new USPTO allowances | 6 | Investing.com | ||
| 18.02. | Tenon Medical, Inc.: Tenon Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion | 392 | ACCESS Newswire | Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy LOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the... ► Artikel lesen | |
| 12.02. | Tenon Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 06.02. | Tenon Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.02. | Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues | 284 | ACCESS Newswire | Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year LOS GATOS... ► Artikel lesen | |
| 28.01. | Tenon Medical reports 90% revenue growth in Q4 2025 | 2 | Investing.com | ||
| 28.01. | Tenon Medical, Inc.: Tenon Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025 | 353 | ACCESS Newswire | Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year.Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year. LOS GATOS... ► Artikel lesen | |
| 04.12.25 | Tenon Medical, Inc.: Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry+ SI Joint Fusion System | 1.922 | ACCESS Newswire | ~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~~ SImmetry+ combines 3D-printed titanium implants, a robust joint decorticator... ► Artikel lesen | |
| 17.11.25 | Tenon Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Tenon Medical raises $2.85 million in private placement | 6 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,500 | -0,56 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,340 | -1,43 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,520 | -0,39 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 36 auf 31 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Die Aktien der Jenaer... ► Artikel lesen | |
| UNITEDHEALTH | 262,40 | 0,00 % | UnitedHealth: Positive News von der US-Regierung - Aktie mit Kurssprung | Die Aktie des Versicherers UnitedHealth zeigte sich am Montag im regulären Handel bereits stark. Sie gehörte mit einem Plus von 1,5 Prozent zu den fünf besten Werten im US-Leitindex Dow Jones Industrial.... ► Artikel lesen | |
| GERRESHEIMER | 17,000 | -3,30 % | Shortseller-Positionen aktuell: u.a. pbb, Gerresheimer, Hugo Boss, LANXESS, Puma, Sartorius, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| MEDTRONIC | 75,42 | +0,37 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 16,780 | -0,59 % | GraniteShares YieldBOOST HIMS ETF declares $0.1161 dividend | ||
| NUGEN MEDICAL DEVICES | 0,011 | -3,51 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| VERU | 2,430 | -4,89 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,550 | -2,52 % | Tempest Therapeutics: Tempest Reports Year End 2025 Financial Results and Provides Business Update | Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing... ► Artikel lesen | |
| TENET | 171,00 | -1,16 % | Cantor Fitzgerald reiterates Tenet Healthcare stock rating on pricing | ||
| PANGENOMIC HEALTH | 0,288 | +1,41 % | Gesundheitssektor nimmt Fahrt auf - Bayer, PanGenomic Health, UnitedHealth Group | Die schlechten Nachrichten für Google bzw. Alphabet reißen nicht ab. Die Europäische Kommission hat ein Verfahren gegen Alphabet, das Mutterunternehmen von Google, eröffnet. Ihr Vorwurf: Verstöße seitens... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 65,72 | -5,60 % | Raymond James nimmt Somnigroup-Aktie in die Favoritenliste auf | ||
| SINTX TECHNOLOGIES | 2,700 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 2,550 | -3,77 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market | Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability... ► Artikel lesen |